CovidFranceV1, Main, Exploration, bibRecord, 000207

[COVID-19, management, therapeutic and vaccine approaches].

Identifieur interne : 000207 ( Main/Exploration ); précédent : 000206; suivant : 000208

[COVID-19, management, therapeutic and vaccine approaches].

Auteurs : Élodie Matusik [France] ; Mériam Ayadi [France] ; Nicolas Picard [France]

Source :

Actualites pharmaceutiques [ 0515-3700 ] ; 2020.

RBID : pubmed:32863556

Abstract

While at the beginning of 2020, the COVID-19 epidemic was spreading at tremendous speed, many scientific teams set to work around the world. The management of severe acute respiratory syndrome coronavirus 2 infections is based on experimental non-specific (symptomatic) or specific (curative) treatments. The vaccine will be the key to long-term immunization.

DOI: 10.1016/j.actpha.2020.08.007
PubMed: 32863556
PubMed Central: PMC7442000

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000294
to stream Main, to step Curation: 000294

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[COVID-19, management, therapeutic and vaccine approaches].</title>
<author><name sortKey="Matusik, Elodie" sort="Matusik, Elodie" uniqKey="Matusik E" first="Élodie" last="Matusik">Élodie Matusik</name>
<affiliation><nlm:affiliation>Département recherche en soins critiques.</nlm:affiliation>
<wicri:noCountry code="no comma">Département recherche en soins critiques.</wicri:noCountry>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Pharmacie, Centre hospitalier de Valenciennes, 114 avenue Desandrouin, 59300 Valenciennes, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Pharmacie, Centre hospitalier de Valenciennes, 114 avenue Desandrouin, 59300 Valenciennes</wicri:regionArea>
<placeName><region type="region" nuts="2">Hauts-de-France</region>
<region type="old region" nuts="2">Nord-Pas-de-Calais</region>
<settlement type="city">Valenciennes</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ayadi, Meriam" sort="Ayadi, Meriam" uniqKey="Ayadi M" first="Mériam" last="Ayadi">Mériam Ayadi</name>
<affiliation wicri:level="3"><nlm:affiliation>Agence nationale de sécurité du médicament et des produits de santé, Pôle antibiotiques-vaccins, 143 boulevard Anatole-France, 93200 Saint-Denis, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Agence nationale de sécurité du médicament et des produits de santé, Pôle antibiotiques-vaccins, 143 boulevard Anatole-France, 93200 Saint-Denis</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Saint-Denis (Seine-Saint-Denis)</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Picard, Nicolas" sort="Picard, Nicolas" uniqKey="Picard N" first="Nicolas" last="Picard">Nicolas Picard</name>
<affiliation wicri:level="3"><nlm:affiliation>Service de pharmacologie, toxicologie et pharmacovigilance, CHU de Limoges, 2 avenue Martin-Luther-King, 87042 Limoges, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de pharmacologie, toxicologie et pharmacovigilance, CHU de Limoges, 2 avenue Martin-Luther-King, 87042 Limoges</wicri:regionArea>
<placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Limousin</region>
<settlement type="city">Limoges</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="4"><nlm:affiliation>Faculté de pharmacie, Département de pharmacologie, Université de Limoges, 2 rue du Docteur-Marcland, 87025 Limoges, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Faculté de pharmacie, Département de pharmacologie, Université de Limoges, 2 rue du Docteur-Marcland, 87025 Limoges</wicri:regionArea>
<placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Limousin</region>
<settlement type="city">Limoges</settlement>
</placeName>
<orgName type="university">Université de Limoges</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32863556</idno>
<idno type="pmid">32863556</idno>
<idno type="doi">10.1016/j.actpha.2020.08.007</idno>
<idno type="pmc">PMC7442000</idno>
<idno type="wicri:Area/Main/Corpus">000294</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000294</idno>
<idno type="wicri:Area/Main/Curation">000294</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000294</idno>
<idno type="wicri:Area/Main/Exploration">000294</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[COVID-19, management, therapeutic and vaccine approaches].</title>
<author><name sortKey="Matusik, Elodie" sort="Matusik, Elodie" uniqKey="Matusik E" first="Élodie" last="Matusik">Élodie Matusik</name>
<affiliation><nlm:affiliation>Département recherche en soins critiques.</nlm:affiliation>
<wicri:noCountry code="no comma">Département recherche en soins critiques.</wicri:noCountry>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Pharmacie, Centre hospitalier de Valenciennes, 114 avenue Desandrouin, 59300 Valenciennes, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Pharmacie, Centre hospitalier de Valenciennes, 114 avenue Desandrouin, 59300 Valenciennes</wicri:regionArea>
<placeName><region type="region" nuts="2">Hauts-de-France</region>
<region type="old region" nuts="2">Nord-Pas-de-Calais</region>
<settlement type="city">Valenciennes</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ayadi, Meriam" sort="Ayadi, Meriam" uniqKey="Ayadi M" first="Mériam" last="Ayadi">Mériam Ayadi</name>
<affiliation wicri:level="3"><nlm:affiliation>Agence nationale de sécurité du médicament et des produits de santé, Pôle antibiotiques-vaccins, 143 boulevard Anatole-France, 93200 Saint-Denis, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Agence nationale de sécurité du médicament et des produits de santé, Pôle antibiotiques-vaccins, 143 boulevard Anatole-France, 93200 Saint-Denis</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Saint-Denis (Seine-Saint-Denis)</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Picard, Nicolas" sort="Picard, Nicolas" uniqKey="Picard N" first="Nicolas" last="Picard">Nicolas Picard</name>
<affiliation wicri:level="3"><nlm:affiliation>Service de pharmacologie, toxicologie et pharmacovigilance, CHU de Limoges, 2 avenue Martin-Luther-King, 87042 Limoges, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de pharmacologie, toxicologie et pharmacovigilance, CHU de Limoges, 2 avenue Martin-Luther-King, 87042 Limoges</wicri:regionArea>
<placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Limousin</region>
<settlement type="city">Limoges</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="4"><nlm:affiliation>Faculté de pharmacie, Département de pharmacologie, Université de Limoges, 2 rue du Docteur-Marcland, 87025 Limoges, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Faculté de pharmacie, Département de pharmacologie, Université de Limoges, 2 rue du Docteur-Marcland, 87025 Limoges</wicri:regionArea>
<placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Limousin</region>
<settlement type="city">Limoges</settlement>
</placeName>
<orgName type="university">Université de Limoges</orgName>
</affiliation>
</author>
</analytic>
<series><title level="j">Actualites pharmaceutiques</title>
<idno type="ISSN">0515-3700</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">While at the beginning of 2020, the COVID-19 epidemic was spreading at tremendous speed, many scientific teams set to work around the world. The management of severe acute respiratory syndrome coronavirus 2 infections is based on experimental non-specific (symptomatic) or specific (curative) treatments. The vaccine will be the key to long-term immunization.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32863556</PMID>
<DateRevised><Year>2020</Year>
<Month>09</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0515-3700</ISSN>
<JournalIssue CitedMedium="Print"><PubDate><Year>2020</Year>
<Month>Aug</Month>
<Day>21</Day>
</PubDate>
</JournalIssue>
<Title>Actualites pharmaceutiques</Title>
<ISOAbbreviation>Actual Pharm</ISOAbbreviation>
</Journal>
<ArticleTitle>[COVID-19, management, therapeutic and vaccine approaches].</ArticleTitle>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actpha.2020.08.007</ELocationID>
<Abstract><AbstractText>While at the beginning of 2020, the COVID-19 epidemic was spreading at tremendous speed, many scientific teams set to work around the world. The management of severe acute respiratory syndrome coronavirus 2 infections is based on experimental non-specific (symptomatic) or specific (curative) treatments. The vaccine will be the key to long-term immunization.</AbstractText>
<CopyrightInformation>© 2020 Elsevier Masson SAS. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Matusik</LastName>
<ForeName>Élodie</ForeName>
<Initials>É</Initials>
<AffiliationInfo><Affiliation>Département recherche en soins critiques.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Pharmacie, Centre hospitalier de Valenciennes, 114 avenue Desandrouin, 59300 Valenciennes, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ayadi</LastName>
<ForeName>Mériam</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Agence nationale de sécurité du médicament et des produits de santé, Pôle antibiotiques-vaccins, 143 boulevard Anatole-France, 93200 Saint-Denis, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Picard</LastName>
<ForeName>Nicolas</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Service de pharmacologie, toxicologie et pharmacovigilance, CHU de Limoges, 2 avenue Martin-Luther-King, 87042 Limoges, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Faculté de pharmacie, Département de pharmacologie, Université de Limoges, 2 rue du Docteur-Marcland, 87025 Limoges, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>fre</Language>
<PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Covid-19, prise en charge, pistes thérapeutiques et vaccinales.</VernacularTitle>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>08</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>France</Country>
<MedlineTA>Actual Pharm</MedlineTA>
<NlmUniqueID>0043545</NlmUniqueID>
<ISSNLinking>0515-3700</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
<Keyword MajorTopicYN="N">coronavirus</Keyword>
<Keyword MajorTopicYN="N">pharmacology</Keyword>
<Keyword MajorTopicYN="N">vaccine</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>9</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>8</Month>
<Day>31</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>8</Month>
<Day>31</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32863556</ArticleId>
<ArticleId IdType="doi">10.1016/j.actpha.2020.08.007</ArticleId>
<ArticleId IdType="pii">S0515-3700(20)30298-6</ArticleId>
<ArticleId IdType="pmc">PMC7442000</ArticleId>
</ArticleIdList>
<pmc-dir>pmcsd</pmc-dir>
        <ReferenceList><Reference><Citation>Lancet. 2020 May 30;395(10238):1695-1704</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32401715</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 May 11;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32392282</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2015 Jan 1;211(1):80-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25030060</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA Intern Med. 2020 Mar 13;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32167524</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect. 2020 Aug;81(2):318-356</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32283154</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 Nov;78(22):12672-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15507655</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA Cardiol. 2020 Apr 23;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32324209</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Trials. 2020 May 24;21(1):422</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32448345</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 Jun 3;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32492084</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2004 Jul 9;319(4):1216-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15194496</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Med Virol. 2020 Jul;92(7):726-730</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32221983</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32205204</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Trends Mol Med. 2013 Dec;19(12):705-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24138818</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antimicrob Agents Chemother. 2020 Jun 23;64(7):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32366720</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 May 7;382(19):1787-1799</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32187464</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Sep 3;383(10):994</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32649078</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JCI Insight. 2019 Feb 21;4(4):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30830861</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccines (Basel). 2014 May 14;2(2):354-79</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26344623</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Infect Dis. 2019 Apr;81:184-190</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30690213</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Rheumatol. 2020 Jul;2(7):e393-e400</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32835245</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Pharmacol Ther. 2020 Aug;108(2):253-263</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32285930</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2020 Apr;580(7805):576-577</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32346146</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 May 22;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32450107</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virol J. 2005 Aug 22;2:69</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16115318</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Microbes Infect. 2020 Jul - Aug;22(6-7):245-253</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32437926</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cochrane Database Syst Rev. 2019 Jul 23;7:CD004477</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31334568</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2020 May 29;368(6494):1012-1015</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32303590</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2012;7(4):e35421</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22536382</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hum Vaccin Immunother. 2016 Sep;12(9):2351-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27269431</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Circ Res. 2020 Jun 5;126(12):1671-1681</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32302265</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Immunol. 2020 Jul;20(7):392-394</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32514035</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>France</li>
</country>
<region><li>Hauts-de-France</li>
<li>Limousin</li>
<li>Nord-Pas-de-Calais</li>
<li>Nouvelle-Aquitaine</li>
<li>Île-de-France</li>
</region>
<settlement><li>Limoges</li>
<li>Saint-Denis (Seine-Saint-Denis)</li>
<li>Valenciennes</li>
</settlement>
<orgName><li>Université de Limoges</li>
</orgName>
</list>
<tree><country name="France"><region name="Hauts-de-France"><name sortKey="Matusik, Elodie" sort="Matusik, Elodie" uniqKey="Matusik E" first="Élodie" last="Matusik">Élodie Matusik</name>
</region>
<name sortKey="Ayadi, Meriam" sort="Ayadi, Meriam" uniqKey="Ayadi M" first="Mériam" last="Ayadi">Mériam Ayadi</name>
<name sortKey="Picard, Nicolas" sort="Picard, Nicolas" uniqKey="Picard N" first="Nicolas" last="Picard">Nicolas Picard</name>
<name sortKey="Picard, Nicolas" sort="Picard, Nicolas" uniqKey="Picard N" first="Nicolas" last="Picard">Nicolas Picard</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000207 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000207 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32863556
   |texte=   [COVID-19, management, therapeutic and vaccine approaches].
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32863556" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidFranceV1

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021

	Serveur d'exploration sur la COVID en France
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur la COVID en France

[COVID-19, management, therapeutic and vaccine approaches].

[COVID-19, management, therapeutic and vaccine approaches].

Source :

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki